ACE and cancer: Medications like calcium channel blockers, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors, trimetazidine, statins, N-acetylcysteine (NAC), and dexrazoxane have demonstrated promise in lowering both the frequency and intensity of cardiotoxic effects linked to cancer therapies [11,12].